Mammography Market is Estimated To Witness High Growth Owing To Increased Breast Cancer Screening Activities


 Mammography Market

The mammography market is estimated to be valued at US$ 2360.16 Mn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Mammography is a specific type of imaging that uses low-dose x-rays to examine breasts. It is used as a diagnostic and screening tool to detect early signs of breast abnormalities, cancer or other issues. Mammography helps in early detection of breast cancer which increases the chances of successful treatment. It produces high quality images of breast tissue and are used by healthcare professionals to screen for and diagnose breast cancer or other issues.

Market key trends:
One of the key trends driving the growth of mammography market is increased breast cancer screening activities across the globe. According to WHO, breast cancer is the most common cancer affecting women worldwide and annual breast cancer screening helps find cancer at an early stage leading to successful treatment. Various government initiatives to spread awareness about breast cancer screening along with mandatory screening programs have increased the uptake of mammography procedures significantly. For instance, the National Breast Cancer Screening Program in the U.S. provides free or low-cost mammograms to underprivileged and older women population. Furthermore, technological advancements including 3D mammography, computer-aided detection of mammograms and molecular breast imaging are enhancing the accuracy of breast cancer diagnosis which is further propelling the demand for mammography equipment.

Porter’s Analysis

Threat of new entrants: Low capital requirement and established brand names lower the threat of new entrants in the mammography market. Bargaining power of buyers: Individual consumers have limited bargaining power due to inelastic demand for mammography services and devices. Whereas large healthcare organizations have significant bargaining power.

Bargaining power of suppliers: Leading equipment manufacturers differentiate their products, increasing customer loyalty and lowering supplier bargaining power. Switching costs are also significant.

Threat of new substitutes: No close substitutes currently exist for mammography in breast cancer screening. Computed tomography (CT) scans are sometimes used but are more expensive and expose patients to radiation.

Competitive rivalry: Intense as major players compete based on technology innovations, geographic expansion, and service quality to gain market share.

SWOT Analysis

Strengths: Early-stage breast cancer detection saves lives and lowers treatment costs. Digital technology enhances image clarity.

Weaknesses: High equipment and maintenance costs. Discomfort during imaging deters some patients. skill required to interpret images.

Opportunities: Rising breast cancer incidence drives screening needs. Untapped growth potential in developing nations. Novel applications of AI in diagnostics.

Threats: Economic slowdowns lower healthcare budgets for new purchases. Stringent regulatory approvals delay product launches. Privacy concerns over data usage.

Key Takeaways

The Global Mammography Market Size is expected to witness high growth, exhibiting CAGR of 9.0% over the forecast period, due to increasing awareness about early cancer detection and favorable government initiatives.

On a regional basis, Asia Pacific region is expected to witness the fastest growth owing to rising healthcare expenditure, large patient pools, and increasing focus of market players. Developed markets like North America and Europe dominated the mammography market in 2023 due to robust healthcare infrastructure and widespread screening programs.

Key players operating in the mammography market are Canon Medical Systems, Carestream Health, Siemens Healthineers, Planmed Oy, Konica Minolta Inc., Metaltronica SpA, Koninklijke Philips NV, General Medical Merate SpA, Hologic Inc., GE Healthcare, and Fujifilm Holdings Corporation, among others. Major players are investing in R&D to develop novel technologies that provide enhanced image quality while reducing radiation exposure.

Comments

Post a Comment

Popular posts from this blog

Training Market Estimated To Witness High Growth Owing To Growing Emphasis on Developing Skillset

Image
  Training Market The Training Market Is Estimated To Be Valued At US$132.2244 Bn In 2023 And Is Expected To Exhibit A CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The training market covers products and services related to developing and enhancing skills through workshops, online programs and classroom instructions. This includes corporate training focused on technical, soft and safety skills for varied industries. The key end users are corporates, government organizations and educational institutes. Market Dynamics: The training market is expected to witness significant growth owing to growing emphasis on developing skills to cope with rising complexity and changing nature of jobs. With rapid digitalization and emerging technologies, job roles are transforming significantly necessitating continuous upskilling and reskilling of workforce. This is driving increased demand for training p...
Read more

Salmonella Testing Is Estimated To Witness High Growth Owing To Rising Food Safety Concerns

Image
Salmonella testing market The Salmonella testing market is estimated to be valued at US$ 2.91 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Salmonella testing market involves detection and identification of Salmonella bacteria that causes food poisoning. The key products in the market are assays, kits and reagents that are used to test food samples, clinical samples and environmental samples for the presence of Salmonella. Major end-users include food processing companies, pharmaceutical companies, clinical laboratories and research institutions. Market Dynamics: Rising global outbreaks of foodborne illnesses caused by Salmonella infection is a major factor driving growth of the Salmonella testing market. According to WHO, non-typhoidal Salmonella causes over 90 million cases of gastroenteritis each year globally. Growing consumer awareness abo...
Read more

Global Lab-on-a-Chip and Microarrays (Biochip) Market Is Estimated To Witness High Growth Owing To Rising Demand for Personalized Medicine and Technological Advancements

Image
  Lab-on-a-Chip and Microarrays (Biochip) Market The Lab-on-a-Chip and Microarrays (Biochip) Market is estimated to be valued at US$ 15,268.0 Mn in 2023 and is expected to exhibit a CAGR of 13.43% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Lab-on-a-chip and microarrays (biochip) are innovative technologies that have revolutionized the field of diagnostics and drug discovery. These devices are used for sample analysis and detection of diseases at a molecular level. Lab-on-a-chip platforms offer benefits such as minimal sample requirement, high-throughput analysis, and cost-effective solutions. They find applications in various areas such as genomics, proteomics, and clinical diagnostics, among others. These biochips have the potential to provide personalized medicine by enabling rapid and accurate diagnosis, leading to effective treatments and improved patient outcomes. Market Dynamics: The market ...
Read more